X-Energy Lands 5 Buy Ratings From Wall Street: Guggenheim Sets Top Price Target at $57
Briefly

X-Energy Lands 5 Buy Ratings From Wall Street: Guggenheim Sets Top Price Target at $57
Six major Wall Street firms initiated coverage of X-Energy, with five bullish ratings and one hold. Guggenheim assigned a Buy rating with a $57 price target, while Jefferies assigned a Hold rating with a $28 target. The stock traded around $27.71, near the 52-week low and below the 52-week high. The bullish case centers on structural demand for small modular reactors tied to AI data center power needs, U.S. energy security policy, and decarbonization. The cautious view emphasizes long commercialization timelines, regulatory approval risk, high capital intensity, and uncertain first-of-a-kind economics. X-Energy develops the Xe-100 advanced small modular reactor for grid power and industrial process heat.
"X-Energy ( NASDAQ:XE) just earned coverage from six major Wall Street firms, with five taking a bullish stance on the advanced nuclear developer. Guggenheim set the high bar with a Buy rating and a $57 price target, while Jefferies anchored the low end with a Hold rating and a $28 target. The coordinated initiations reflect a recently public company emerging from its IPO quiet period."
"For watchful investors, the takeaway is straightforward: institutional consensus on X-Energy stock is constructive, but the wide dispersion in price targets signals genuine disagreement about valuing a pre-commercial nuclear story. X-Energy shares changed hands near $27.71 in Tuesday trading, fairly close to the 52-week low of $25.06 and well below the $37.10 high."
"The bull thesis hinges on structural demand. X-Energy has been a notable beneficiary of the SMR investment thesis tied to AI data center power demand, U.S. energy security policy, and decarbonization needs. Guggenheim's $57 price target sits at nearly double the Jefferies floor, signaling the most optimistic view sees significant commercialization upside."
"Jefferies's more cautious Hold call reflects the other side of the ledger. SMR commercialization timelines are long, regulatory approval risk is real, capital intensity is enormous, and first-of-a-kind project economics are uncertain. That tension between long-dated optionality and near-term execution risk defines the central debate around X-Energy stock."
Read at 24/7 Wall St.
Unable to calculate read time
[
|
]